{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:04:49Z","timestamp":1794002689450,"version":"4.8.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.antiviral.2016.11.018","type":"journal-article","created":{"date-parts":[[2016,12,3]],"date-time":"2016-12-03T23:45:38Z","timestamp":1480808738000},"page":"47-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":118,"special_numbering":"C","title":["Evaluation of anti-Zika virus activities of broad-spectrum antivirals and NIH clinical collection compounds using a cell-based, high-throughput screen assay"],"prefix":"10.1016","volume":"138","author":[{"given":"Robert S.","family":"Adcock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Kyu","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer E.","family":"Golden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Hoon","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2016.11.018_bib1","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1111\/j.1462-5822.2009.01345.x","article-title":"Alternative infectious entry pathways for dengue virus serotypes into mammalian cells","author":"Acosta","year":"2009","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.antiviral.2016.11.018_bib2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.steroids.2009.10.005","article-title":"An overview on 5alpha-reductase inhibitors","author":"Aggarwal","year":"2010","journal-title":"Steroids"},{"key":"10.1016\/j.antiviral.2016.11.018_bib3","doi-asserted-by":"crossref","first-page":"e0004682","DOI":"10.1371\/journal.pntd.0004682","article-title":"Characterization of Lethal Zika virus infection in AG129 mice","volume":"10","author":"Aliota","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.antiviral.2016.11.018_bib4","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.micinf.2008.01.009","article-title":"Statin-induced inhibition of HIV-1 release from latently infected U1 cells reveals a critical role for protein prenylation in HIV-1 replication","author":"Amet","year":"2008","journal-title":"Microbes Infect."},{"key":"10.1016\/j.antiviral.2016.11.018_bib5","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.chom.2016.07.004","article-title":"A\u00a0screen of FDA-approved drugs for inhibitors of Zika virus infection","author":"Barrows","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.antiviral.2016.11.018_bib6","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/0035-9203(56)90090-6","article-title":"Zika virus infection experimentally induced in a human volunteer","volume":"50","author":"Bearcroft","year":"1956","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2016.11.018_bib7","doi-asserted-by":"crossref","first-page":"6739","DOI":"10.1073\/pnas.1017142108","article-title":"Identification of broad-spectrum antiviral compounds and assessment of the druggability of their target for efficacy against respiratory syncytial virus (RSV)","author":"Bonavia","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2016.11.018_bib8","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1172\/JCI105025","article-title":"The effect of 6-azauridine administration on de novo pyrimidine production in chronic myelogenous leukemia","author":"Bono","year":"1964","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.antiviral.2016.11.018_bib9","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S1473-3099(16)00095-5","article-title":"Detection and sequencing of Zika virus from amniotic fluid of fetuses with microcephaly in Brazil: a case study","volume":"16","author":"Calvet","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.11.018_bib10","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S0140-6736(16)00562-6","article-title":"Guillain-Barre Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study","volume":"387","author":"Cao-Lormeau","year":"2016","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.antiviral.2016.11.018_bib11","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1056\/NEJMc1602964","article-title":"Zika virus associated with meningoencephalitis","volume":"374","author":"Carteaux","year":"2016","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.antiviral.2016.11.018_bib12","doi-asserted-by":"crossref","first-page":"10543","DOI":"10.1128\/JVI.78.19.10543-10555.2004","article-title":"Infectious entry of West Nile virus occurs through a clathrin-mediated endocytic pathway","author":"Chu","year":"2004","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.11.018_bib13","doi-asserted-by":"crossref","first-page":"10543","DOI":"10.1128\/JVI.78.19.10543-10555.2004","article-title":"Infectious entry of West Nile virus occurs through a clathrin-mediated endocytic pathway","volume":"78","author":"Chu","year":"2004","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.11.018_bib14","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.1128\/AAC.00282-16","article-title":"Discovery of a broad-spectrum antiviral compound that inhibits pyrimidine biosynthesis and establishes a type 1 interferon-independent antiviral state","author":"Chung","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2016.11.018_bib15","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.3390\/molecules15031690","article-title":"HTS-driven discovery of new chemotypes with West Nile Virus inhibitory activity","author":"Chung","year":"2010","journal-title":"Molecules"},{"key":"10.1016\/j.antiviral.2016.11.018_bib16","doi-asserted-by":"crossref","first-page":"e1004213","DOI":"10.1371\/journal.ppat.1004213","article-title":"Discovery of a novel compound with anti-venezuelan equine encephalitis virus activity that targets the nonstructural protein 2","author":"Chung","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2016.11.018_bib17","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1128\/AEM.18.1.14-20.1969","article-title":"In\u00a0vitro antiviral activity of mycophenolic acid and its reversal by guanine-type compounds","volume":"18","author":"Cline","year":"1969","journal-title":"Appl. Microbiol."},{"key":"10.1016\/j.antiviral.2016.11.018_bib18","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0166-3542(02)00185-7","article-title":"Interferon, ribavirin, 6-azauridine and glycyrrhizin: antiviral compounds active against pathogenic flaviviruses","volume":"58","author":"Crance","year":"2003","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.11.018_bib19","doi-asserted-by":"crossref","first-page":"6895","DOI":"10.1073\/pnas.111085598","article-title":"RNA virus error catastrophe: direct molecular test by using ribavirin","volume":"98","author":"Crotty","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2016.11.018_bib20","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.antiviral.2005.04.002","article-title":"Error-prone replication of West Nile virus caused by ribavirin","volume":"67","author":"Day","year":"2005","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.11.018_bib21","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1084\/jem.20040061","article-title":"Statins inhibit HIV-1 infection by down-regulating Rho activity","author":"del Real","year":"2004","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.antiviral.2016.11.018_bib22","doi-asserted-by":"crossref","first-page":"11915","DOI":"10.1128\/JVI.01207-14","article-title":"Inhibition of enterovirus 71 by adenosine analog NITD008","author":"Deng","year":"2014","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.11.018_bib23","doi-asserted-by":"crossref","first-page":"5259","DOI":"10.1073\/pnas.85.14.5259","article-title":"Homozygous deletion of the alpha- and beta 1-interferon genes in human leukemia and derived cell lines","author":"Diaz","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2016.11.018_bib24","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0035-9203(52)90043-6","article-title":"Zika virus. II. Pathogenicity and physical properties","volume":"46","author":"Dick","year":"1952","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2016.11.018_bib25","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0035-9203(52)90042-4","article-title":"Zika virus. I. Isolations and serological specificity","volume":"46","author":"Dick","year":"1952","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2016.11.018_bib26","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1056\/NEJMoa0805715","article-title":"Zika virus outbreak on Yap Island, Federated States of Micronesia","volume":"360","author":"Duffy","year":"2009","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.antiviral.2016.11.018_bib27","doi-asserted-by":"crossref","first-page":"12062","DOI":"10.1128\/JVI.78.21.12062-12065.2004","article-title":"Statin compounds reduce human immunodeficiency virus type 1 replication by preventing the interaction between virion-associated host intercellular adhesion molecule 1 and its natural cell surface ligand LFA-1","author":"Giguere","year":"2004","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.11.018_bib28","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1128\/AAC.45.4.1231-1237.2001","article-title":"Antiviral activity of lovastatin against respiratory syncytial virus in\u00a0vivo and in\u00a0vitro","author":"Gower","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2016.11.018_bib29","doi-asserted-by":"crossref","first-page":"8880","DOI":"10.1128\/JVI.00354-15","article-title":"Biology of Zika virus infection in human skin cells","volume":"89","author":"Hamel","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.11.018_bib30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/infdis\/133.1.7","article-title":"Effects of cytosine arabinoside, adenine arabinoside, and 6-azauridine on rabies virus in\u00a0vitro and in\u00a0vivo","volume":"133","author":"Harmon","year":"1976","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.11.018_bib31","doi-asserted-by":"crossref","first-page":"5777","DOI":"10.1073\/pnas.1101143108","article-title":"Broad-spectrum antiviral that interferes with de novo pyrimidine biosynthesis","author":"Hoffmann","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2016.11.018_bib32","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1128\/JVI.01399-12","article-title":"Japanese encephalitis virus infects neuronal cells through a clathrin-independent endocytic mechanism","author":"Kalia","year":"2013","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.11.018_bib63","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.virol.2005.11.051","article-title":"Venezuelan equine encephalitis virus entry mechanism requires late endosome formation and resists cell membrane cholesterol depletion","volume":"347","author":"Kolokoltsov","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2016.11.018_bib33","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3201\/eid2205.160065","article-title":"Phylogeny of Zika virus in Western Hemisphere, 2015","volume":"22","author":"Lanciotti","year":"2016","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.11.018_bib34","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.chom.2016.03.010","article-title":"A\u00a0mouse model of Zika virus pathogenesis","volume":"19","author":"Lazear","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.antiviral.2016.11.018_bib35","first-page":"25","article-title":"Structures of human dihydroorotate dehydrogenase in complex with antiproliferative agents","author":"Liu","year":"2000","journal-title":"Struct. Lond. Engl. 1993"},{"key":"10.1016\/j.antiviral.2016.11.018_bib36","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.bbrc.2006.06.107","article-title":"Role of simvastatin and methyl-beta-cyclodextrin [corrected] on inhibition of poliovirus infection","author":"Liu","year":"2006","journal-title":"Biochem. Biophys. Res. Co."},{"key":"10.1016\/j.antiviral.2016.11.018_bib37","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.antiviral.2016.03.013","article-title":"In\u00a0vitro antiviral activity of adenosine analog NITD008 against tick-borne flaviviruses","author":"Lo","year":"2016","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.11.018_bib38","doi-asserted-by":"crossref","first-page":"e1003678","DOI":"10.1371\/journal.ppat.1003678","article-title":"Inhibition of pyrimidine biosynthesis pathway suppresses viral growth through innate immunity","author":"Lucas-Hourani","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2016.11.018_bib39","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.devcel.2006.04.002","article-title":"Dynasore, a cell-permeable inhibitor of dynamin","author":"Macia","year":"2006","journal-title":"Dev. Cell"},{"key":"10.1016\/j.antiviral.2016.11.018_bib40","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1128\/AAC.44.4.859-866.2000","article-title":"Broad-spectrum antiviral activity of the IMP dehydrogenase inhibitor VX-497: a comparison with ribavirin and demonstration of antiviral additivity with alpha interferon","volume":"44","author":"Markland","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2016.11.018_bib41","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nrm2216","article-title":"Pathways of clathrin-independent endocytosis","volume":"8","author":"Mayor","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.antiviral.2016.11.018_bib42","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1476-5381.2011.01346.x","article-title":"The proton translocation domain of cellular vacuolar ATPase provides a target for the treatment of influenza A virus infections","author":"Muller","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.antiviral.2016.11.018_bib43","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3390\/v6010069","article-title":"Flavivirus entry receptors: an update","volume":"6","author":"Perera-Lecoin","year":"2013","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2016.11.018_bib44","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1161\/01.CIR.0000109485.79183.81","article-title":"Hydroxymethyl-glutaryl coenzyme a reductase inhibition limits cytomegalovirus infection in human endothelial cells","author":"Potena","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.antiviral.2016.11.018_bib45","unstructured":"PubChem CID 91632869 PubChem Database."},{"key":"10.1016\/j.antiviral.2016.11.018_bib46","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.4269\/ajtmh.16-0111","article-title":"Characterization of a novel murine model to study Zika virus","volume":"94","author":"Rossi","year":"2016","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2016.11.018_bib47","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMe1601862","article-title":"Zika virus and microcephaly","author":"Rubin","year":"2016","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.antiviral.2016.11.018_bib48","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1473-3099(06)70361-9","article-title":"New insights into the antiviral effects of chloroquine","volume":"6","author":"Savarino","year":"2006","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.11.018_bib49","doi-asserted-by":"crossref","first-page":"e1000244","DOI":"10.1371\/journal.ppat.1000244","article-title":"Dissecting the cell entry pathway of dengue virus by single-particle tracking in living cells","volume":"4","author":"Schaar","year":"2008","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2016.11.018_bib50","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0035-9203(64)90201-9","article-title":"Zika virus infection in man","volume":"58","author":"Simpson","year":"1964","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2016.11.018_bib51","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3851\/IMP2105","article-title":"D282, a non-nucleoside inhibitor of influenza virus infection that interferes with de novo pyrimidine biosynthesis","author":"Smee","year":"2012","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.antiviral.2016.11.018_bib52","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3390\/v3020160","article-title":"Flavivirus cell entry and membrane fusion","volume":"3","author":"Smit","year":"2011","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2016.11.018_bib53","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1517\/14656566.2.8.1317","article-title":"Ribavirin - current status of a broad spectrum antiviral agent","volume":"2","author":"Snell","year":"2001","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.antiviral.2016.11.018_bib54","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006015.pub3","article-title":"Finasteride for benign prostatic hyperplasia","author":"Tacklind","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.antiviral.2016.11.018_bib55","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1083\/jcb.116.2.339","article-title":"Membrane fusion process of Semliki Forest virus. I: low pH-induced rearrangement in spike protein quaternary structure precedes virus penetration into cells","author":"Wahlberg","year":"1992","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.antiviral.2016.11.018_bib56","doi-asserted-by":"crossref","first-page":"6548","DOI":"10.1128\/JVI.02510-10","article-title":"Inhibition of dengue virus through suppression of host pyrimidine biosynthesis","author":"Wang","year":"2011","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.11.018_bib57","doi-asserted-by":"crossref","first-page":"19755","DOI":"10.1074\/jbc.M313796200","article-title":"Salicylihalamide A inhibits the V0 sector of the V-ATPase through a mechanism distinct from bafilomycin A1","author":"Xie","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.antiviral.2016.11.018_bib58","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nm.4184","article-title":"Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen","author":"Xu","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2016.11.018_bib59","unstructured":"Xu, M., Lee, E.M., Wen, Z., Cheng, Y., Huang, W.K., Qian, X., Tcw, J., Kouznetsova, J., Ogden, S.C., Hammack, C., et\u00a0al. (2016b). qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human astrocytoma cells (PubChem)."},{"key":"10.1016\/j.antiviral.2016.11.018_bib60","doi-asserted-by":"crossref","first-page":"15865","DOI":"10.1073\/pnas.2237238100","article-title":"Disruption of hepatitis C virus RNA replication through inhibition of host protein geranylgeranylation","author":"Ye","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2016.11.018_bib61","doi-asserted-by":"crossref","first-page":"20435","DOI":"10.1073\/pnas.0907010106","article-title":"An adenosine nucleoside inhibitor of dengue virus","volume":"106","author":"Yin","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2016.11.018_bib62","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A\u00a0simple statistical parameter for use in evaluation and validation of high throughput screening assays","author":"Zhang","year":"1999","journal-title":"J.\u00a0Biomol. Screen."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216304582?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216304582?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,27]],"date-time":"2020-09-27T18:37:40Z","timestamp":1601231860000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354216304582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":63,"alternative-id":["S0166354216304582"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.11.018","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of anti-Zika virus activities of broad-spectrum antivirals and NIH clinical collection compounds using a cell-based, high-throughput screen assay","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.11.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}